| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/12/2011 | CA2393312C Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 07/12/2011 | CA2373972C Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 07/12/2011 | CA2341336C Elongase genes and uses thereof |
| 07/12/2011 | CA2291514C Methods for evaluating tissue morphogenesis and activity |
| 07/07/2011 | WO2011081523A1 Interferon analogs |
| 07/07/2011 | WO2011081173A1 Tetracyclic compound |
| 07/07/2011 | WO2011080269A2 Pharmaceutical preparations comprising a cos releasing compound |
| 07/07/2011 | WO2011079841A1 Beta-carbolines for use in the treatment of hearing loss and vertigo |
| 07/07/2011 | WO2011079349A1 Okadaella gastrococcus and cancer |
| 07/07/2011 | WO2011051966A3 Pharmaceutical compositions for treatment/prophylaxis of non-alcoholic fatty liver disease |
| 07/07/2011 | WO2011031099A3 Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same |
| 07/07/2011 | US20110167512 Hybrid artichoke variety nun 4006 ar |
| 07/07/2011 | US20110166320 Somatostatin analogues |
| 07/07/2011 | US20110166183 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| 07/07/2011 | US20110166178 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase |
| 07/07/2011 | US20110166174 Compounds modulating c-kit and c-fms activity and uses therefor |
| 07/07/2011 | US20110166173 3,5-disubstututed 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors |
| 07/07/2011 | US20110166159 Compounds that modulate intracellular calcium |
| 07/07/2011 | US20110166158 Substituted phenylamine carboxamide analogs as mglur5 negative allosteric modulators and methods of making and using the same |
| 07/07/2011 | US20110166157 2-Substituted-3-Phenylpropionic Acid Derivatives and Their Use in the Treatment of Inflammatory Bowel Disease |
| 07/07/2011 | US20110166148 Treatment of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 07/07/2011 | US20110166145 Stabilization of hypoxia inducible factor (HIF) alpha |
| 07/07/2011 | US20110166142 2-substituted isoflavonoid compounds, medicaments and uses |
| 07/07/2011 | US20110166136 Calcium Ion Channel Modulators & Uses Thereof |
| 07/07/2011 | US20110166124 Tricyclic spirocycle derivatives and methods of use |
| 07/07/2011 | US20110166112 Method for stimulating platelet production |
| 07/07/2011 | US20110166103 Boron-containing small molecules |
| 07/07/2011 | US20110166100 Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease |
| 07/07/2011 | US20110166099 Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer |
| 07/07/2011 | US20110166098 Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease |
| 07/07/2011 | US20110166093 Use of adenosine receptor agonists in therapy |
| 07/07/2011 | US20110166090 18-Membered Macrocycles and Analogs Thereof |
| 07/07/2011 | US20110166069 Compositions and methods for stimulating gastrointestinal motility |
| 07/07/2011 | US20110165599 Monoclonal antibody therapy for pancreas cancer |
| 07/07/2011 | US20110165277 Biological Materials and Uses Thereof |
| 07/07/2011 | US20110165251 Liquid dosage compositions of stable nanoparticulate active agents |
| 07/07/2011 | US20110165231 Treatment of Fructose Malabsorption |
| 07/07/2011 | US20110165230 Attenuated live vaccines |
| 07/07/2011 | US20110165229 Compositions and Methods for Treatment |
| 07/07/2011 | US20110165228 Compositions and Methods for Treatment |
| 07/07/2011 | US20110165224 Vaccines for inclusion body hepatitis |
| 07/07/2011 | US20110165198 Method for reducing lipid absorption by an animal |
| 07/07/2011 | US20110165167 Noval madcam antibodies |
| 07/07/2011 | US20110165166 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 07/07/2011 | US20110165158 Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist |
| 07/07/2011 | US20110165127 Dairy-derived probiotic compositions and uses thereof |
| 07/07/2011 | US20110165125 Methods for enhancing energy metabolism |
| 07/07/2011 | US20110165096 Ficus Extracts Having Angiogenesis Ihibiting Activity And Methods Of Isolating And using The Same |
| 07/07/2011 | US20110165078 Specific binding members against synaptophysin |
| 07/07/2011 | US20110165066 Interleukin-13 binding proteins |
| 07/07/2011 | US20110165063 Il-1 binding proteins |
| 07/07/2011 | DE102009028929A1 Heterocyclisch-substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and their use |
| 07/07/2011 | CA2786090A1 Interferon analogs |
| 07/06/2011 | EP2341068A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 07/06/2011 | EP2341052A1 Ring-fused morpholine derivative having pi3k-inhibiting activity |
| 07/06/2011 | EP2341049A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as PTPASE 1B inhibitors |
| 07/06/2011 | EP2341045A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid (acyloxy)alkyl or ((alkoxycarbonyl)oxy)alkyl ester as SPLA2 inhibitor |
| 07/06/2011 | EP2340841A1 Osteogenesis promoter comprising [4-(methylthio)phenylthio]methanebisphosphonic acid or pharmaceutically acceptable salt thereof as active ingredient |
| 07/06/2011 | EP2340830A2 Hepatitis C Virus Inhibitors |
| 07/06/2011 | EP2340821A1 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient |
| 07/06/2011 | EP2340808A1 Synergic combination of phenylpropanoids, such as verbascoside or teupolioside, and mesalamine |
| 07/06/2011 | EP2340035A1 Treatment of fructose malabsorption |
| 07/06/2011 | EP2340018A2 Water insoluble polymer: starch-based film coatings for colon targeting |
| 07/06/2011 | EP1877050B1 Substituted beta-lactams and their use in medicine |
| 07/06/2011 | EP1317283B1 Tweak receptor agonists as anti-angiogenic agents |
| 07/06/2011 | EP1228076B1 A substantially cell membrane impermeable compound and use thereof |
| 07/06/2011 | EP1173484B1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 07/06/2011 | CN1988899B The euphorbia lunulate bge extractant and production method and use thereof |
| 07/06/2011 | CN1814127B Shenbao preparation, its preparing method and quality control method |
| 07/06/2011 | CN102119217A Novel lipid formulations for nucleic acid delivery |
| 07/06/2011 | CN102118976A Nutritional composition for infants delivered via caesarean section |
| 07/06/2011 | CN102115733A Construction method and application of hepatic tumor gene treatment system capable of administrating intravenously |
| 07/06/2011 | CN102115482A Annatto oligosaccharide, preparation method and usage thereof |
| 07/06/2011 | CN102114232A Chinese medicinal preparation for preventing and treating atony of forestomach of dairy cows and preparation method thereof |
| 07/06/2011 | CN102114227A Pharmaceutical composition for treating hepatitis B and cirrhosis |
| 07/06/2011 | CN102114224A Traditional Chinese compound for treating fatty liver |
| 07/06/2011 | CN102114218A Traditional Chinese medicine for tonifying kidney, strengthening yang and resisting fatigue and preparation method thereof |
| 07/06/2011 | CN102114211A Chinese herbal medicine for treating hepatopathy |
| 07/06/2011 | CN102114202A Liver-protecting composition and preparation method thereof |
| 07/06/2011 | CN102114200A Pill with function of relaxing bowels and preparation method thereof |
| 07/06/2011 | CN102114193A Traditional Chinese medicine for treating keratomalacia due to vitamin A deficiency |
| 07/06/2011 | CN102114192A Traditional Chinese medicine for treating diabetic constipation |
| 07/06/2011 | CN102114191A Traditional Chinese medicine for treating diabetic constipation |
| 07/06/2011 | CN102114190A Chinese medicine for treating diabetic constipation |
| 07/06/2011 | CN102114188A Enema Chinese medicine for treating hepatic encephalopathy in prodromal period |
| 07/06/2011 | CN102114186A Traditional Chinese medicine composition for treating esophageal carcinoma |
| 07/06/2011 | CN102114174A Traditional Chinese medicine for treating acute cholecystitis |
| 07/06/2011 | CN102114167A Chinese medicinal oral decoction for treating rectal cancer |
| 07/06/2011 | CN102114164A Application of traditional Chinese medicine preparation in treating oral leukoplakia and preventing diseases caused by oral leukoplakia canceration |
| 07/06/2011 | CN102114156A Traditional Chinese medicine oral decoction for treating liver cancer |
| 07/06/2011 | CN102114154A Oral traditional Chinese medicine decoction for treating gastric cancer |
| 07/06/2011 | CN102114152A Medicament for radically curing incapability of eating or drinking during advanced esophageal cancer and preparation method thereof |
| 07/06/2011 | CN102114148A Traditional Chinese medicine for treating diabetic gastroplegia |
| 07/06/2011 | CN102114147A Traditional Chinese medicine for treating diabetic gastroparalysis |
| 07/06/2011 | CN102114139A Traditional Chinese medicine for treating liver cancer |
| 07/06/2011 | CN102114137A Traditional Chinese medicine oral decoction for treating chronic appendicitis |
| 07/06/2011 | CN102114136A Traditional Chinese medicine composition for treating liver cancer |
| 07/06/2011 | CN102114124A Traditional Chinese medicine oral decoction for treating toothache |
| 07/06/2011 | CN102114116A Traditional Chinese medicine for treating esophageal carcinoma |
| 07/06/2011 | CN102114113A Preparation method of Chinese pulsatilla root decoction granules |